Navigation Links


Bayer at Biology News

Bayer at Biology Products
Bayer at Biology Technology

Third Wave agrees to drop Chiron, Bayer patent lawsuits

Third Wave said that no licenses or payments were made and did not disclose other terms of the agreement. This leaves Third Wave with only one remaining open patent...

Third Wave files patent suits against Digene, Chiron and Bayer

The company last Friday filed suit against seeking a court ruling supp...

EraGen cystic fibrosis test to be distributed worldwide through Bayer

The new assay can be automated for mutation carrier screening and neonatal and newborn testing. The agreement also allows Bayer He...
Bayer at Medicine News

Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths

Baycol is a prescription drug manufactured by Bayer Pharmaceuticals. Baycol, which was initially approved by the FDA, belongs to a statin group of drugs that lowers cholesterol by blocking enzymes that are essential in the synthesis of cholesterol in the body. Bayer Pharmaceuticals has voluntarily recalled its cholesterol drug Baycol( cerivastatin ) because // it has been linked to app...

Bayer Wins Positive Response For Marketing Its Cancer Drug

European officials have given the green signal for Bayer AG and its partner Onyx Pharmaceuticals Inc., for marketing their new drug to treat kidney cancer//. The opinion of the European Committee for Medicinal Products for Human Use (CHMP) of the drug Nexavar would now be passed onto the European Commission. A positive ruling by the commission could pave the way for a marke...

Genomatix Licensed By Bayer Healthcare

Genomatix is a microarray platform which is now licensed by Bayer HealthCare. It enables biologists and bio-informaticians to analyze chip raw data//. It employs the latest genomic annotation. It combines both literature and pathway mining in a single coherent system. ‘After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector....

Bayer to Market Biocon Insulin in China

Indian biotech major Biocon Ltd has roped in Bayer HealthCare to market its recombinant human insulin Insugen in the Chinese market, the company //said in a statement Wednesday. The Bangalore-based biotech firm plans to launch Insugen in China by 2007-08 after completing the registration trials and seeking the regulatory approvals. "The marketing tie-up with Bayer will be...

Test for Esophageal Reflux Licensed to Bayer by University

A new test for esophageal reflux disease developed by a Wake Forest University Health Sciences (WFUHS) otolaryngologist has been licensed to Bayer HealthCare’s Diagnostics Division by WFUHS.// The test, which detects the presence of human pepsin 3b in a patient’s saliva, was developed by Jamie Koufman, M.D., then professor of otolaryngology at Wake Forest University School of Medicine an...

More>>

Bayer at Medicine Products

Bayer Immuno 1 Immunoassay Analyzer

Description:A fully automated, random access immunoassay instrument with over 50 assays available worldwide. thyroid, reproductive endocrinology, tumor marker, therapeutic drug, serology, anemia and cardiac testing can be performed on a system designed to maximize your workflow efficiency....
Company:Siemens Medical Solutions Diagnostics

Liquichek Blood Gas Plus CO-Oximeter Control (Bayer 800 Series)

Description:Liquichek Blood Gas Plus CO-Oximeter Control (Bayer 800 Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximeter (Bayer 270 and 800 series) instrumentation. This control is recommended for use on Bayer 800 Rapidlab Series instruments in CO-Oximeter analysis....
Company:Bio-Rad Laboratories

CC 525 Blood Gas, Electrolyte, Metabolite, CO-Oximeter (Bayer) Control

Description:CC 525 is an assayed quality control material used for monitoring the performance of blood gas, electrolyte, metabolite, and CO-Oximeter instrumentation. The unique formulation of this control makes it the ideal choice for Bayer 800 Series analyzers. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Company:RNA Medical

RNA1c Control for Bayer DCA 2000 and 2000 + Analyzers

Description:RNA1c Control is an assayed quality control material used for monitoring the performance of Bayer DCA Analyzers that measure Hemoglobin A1c. It may be used on DCA 2000 and 2000+ analyzers....
Company:RNA Medical

CC 525 Blood Gas, Electrolyte, Metabolite, CO-Oximeter (Bayer®) Control

Description:CC 525 is an assayed quality control material used for monitoring the performance of blood gas, electrolyte, metabolite, and CO-Oximeter instrumentation. The unique formulation of this control makes it the ideal choice for Bayer 800 Series analyzers. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Company:RNA Medical

More>>

Bayer at Medicine Technology

Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN

Interim analysis of Phase 2 comparative study showed significantresults in favor of alemtuzumab versus Rebif CAMBRIDGE, Mass. and WAYNE, N.J., May 02, 2007/PRNewswire-FirstCall/ -- Genzyme Corporation and Bayer HealthCarePharmaceutical today announced detailed interim results from theCAMMS223 Phase 2 study. This interim analysis of all patient datathrough at least twenty-four months from...
Other TagsUpgradeUpgradeUpgradeOperationOperationSurgeonSurgeonOppositionValentine
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
(Date:8/20/2008)...ction and Mental Health (CAMH) is proud to announc...da Foundation for Innovation (CFI) into research t...reatment and prevention of mental illness and addi...unding from the Large-Scale Institutional Endeavou...allow CAMH to leverage our scientific strengths, a...
(Date:8/19/2008)...el gonadotrophs , Although the basic developme...t has been harder to associate specific changes in...d cell population. In an article on p. 546 of the ..., Feng et al. take the approach of comparing the n...t were immortalized at different stages of develop...
(Date:8/19/2008)...19, 2008 An international team led by NYU Cancer ...egulates the formation of cilia, which are found o...al to normal cell function. , The new report, ...lected as the featured publication of the open-acc...ork together to regulate the formation of primary ...
(Date:8/19/2008)...9, 2008 -- Elsevier, a leading global healthcare a...nalists in The Elsevier Grand Challenge, a competi...e tools innovating how Life Sciences information i...ists were chosen by a distinguished panel of judge...range of approaches involving semantics, visualiza...
Breaking Biology News(10 mins):Large-scale investment catapults CAMH's mental illness and addiction research forward 2September 2008 Biology of Reproduction highlights 2NYU scientists identify critical protein complex in formation of cell cilia 2Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 2Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 3Anapol Schwartz Attorney Representing Trasylol 28R 29 Victims Says Medical Study Confirming Heart Bypass Drug Mortality Risk to Open Floodgates fo 12384 1Anapol Schwartz Attorney Representing Trasylol 28R 29 Victims Says Medical Study Confirming Heart Bypass Drug Mortality Risk to Open Floodgates fo 12384 2PPD Announces Plan to Repurchase Shares of its Common Stock 3436 1PPD Announces Plan to Repurchase Shares of its Common Stock 3436 2Cadence Pharmaceuticals Completes 2449 3 Million Registered Direct Offering 3432 1Cadence Pharmaceuticals Completes 2449 3 Million Registered Direct Offering 3432 2Cadence Pharmaceuticals Completes 2449 3 Million Registered Direct Offering 3432 3NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars says MIM President Bob Peters 1398 1NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars says MIM President Bob Peters 1398 2
Other Contentsexpansionexpansionexpansionexpansionexpansionexpansionexpansionexpansionexpansionrepeatrepeatrepeatrepeatrepeatrepeatrepeatrepeattriplettriplettrisomytrisomytrisomytrisomytropismbreedingbreedingbreedingbreedingtruetruetruetruetruetruetruetruetruefeetfeetfeetfeetfeetfeetfeetfeet